Associate Professor, Chief Physician
Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University, Denmark
Carsten Utoft Niemann, MD, PhD is a clinical hematologist, associate professor at Rigshospitalet, Copenhagen University Hospital, chairing the Nordic CLL Study Group, heading the CLL laboratory and clinical CLL research program at Rigshospitalet, Denmark. Combining genetic and functional characterization of CLL and microenvironmental cells, MRD testing and diagnostic work up for CLL based on the EuroMRD and ERIC collaborations, along with epidemiological studies. Impacting current practice in CLL, co-authoring ESMO guidelines, TP53 guidelines, flowcytometry- and MRD-guidelines for CLL Founding member for the clinical GAIA/CLL13, VISION/HO141, HO158, HO159, AETHER/HO165, PERSEUS, CLL17 and CLL18 trials, testing targeted therapy in CLL. Founder of the PreVent-ACaLL phase 2-3 trial, the first Machine Learning based clinical trial in CLL. Thus, applying a uniquely strong background across all the disciplines needed for translational research in CLL, feeding into extended decision matrices for lymphoid malignancies based on medical Artificial Intelligence for precision medicine.
